Differential expression of nesfatin-1 in intestinal tissues of premature infants with necrotizing enterocolitis and and its mechanism

AIM To analyze the expression of nesfatin-1 in intestinal tissues of premature infants with necrotizing enterocolitis （NEC）， and to explore the effect of nesfatin-1 on lipopolysacharide （LPS）-induced enterocytes and its mechanism. METHODS The intestinal tissues were obtained from infants who underwent intestinal surgery for NEC in our hospital from 2017 to 2019. The mRNA expression of nesfatin-1 in the tissue samples of NEC were evaluated by RT-qPCR. Human fetal normal colon epithelial HCoEpiC cells and human colon cancer Caco-2 cells were used as research objects. The effect of nesfatin-1 on the secretion of cytokines was measured by ELISA. Western blot was used to analyze the protein expression of nesfatin-1 and Toll-like receptor 4 （TLR4）， NLRP3， AIM2， caspase-1 and ASC， and co-immunoprecipitation assay were conducted to explore the relation between nesfatin-1 and TLR4. RESULTS The expression of nesfatin-1 in NEC preterm infants was significantly lower than that in the healthy group （P<0.01）. Compared with control group， the expression of nesfatin-1 in HCo Epic cells and HT-29 cells induced by LPS was decreased （P<0.01）， while the transfection of nesfatin-1 reversed the stimulation of LPS， and the over-expression of nesfatin-1 decreased the levels of tumor necrosis factor-α （TNF-α） and interleukin-6 （IL-6）， and increased the level of IL-10 （P<0.05）. In addition， nesfatin-1 over-expression inhibited the expression of NLRP3， AIM2， caspase-1 and ASC. The expression of TLR4 in NEC tissue samples was significantly higher than that in healthy infants （P<0.05）. Pearson correlation analysis showed that there was a significant negative correlation between nesfatin-1 and TLR4 （r=-0.816， P<0.01）. TLR4 was found to co-precipitate with nesfatin-1. CONCLUSION Nesfatin-1 protects intestinal cells from LPS induced inflammation by targeting TLR4， which may be a potential target of anti-NEC therapy.